Baxter

Baxter BioPharma Solutions to provide manufacturing services for Novavax’s COVID-19 vaccine candidate

12-Jan-2021 By Rachel Arthur

Baxter BioPharma Solutions' sterile manufacturing agreement with Novavax will help increase commercial production of the vaccine in Europe and the UK.

Spotlight

Pic:getty/bluejayphoto

Swissmedic gives Moderna COVID-19 vaccine the green light

New antibody discovery platform could help accelerate CAR-T therapeutic development

© GettyImages/vladans

Boosting COVID-19 vaccines supplies: EU concludes exploratory talks with Valneva

© GettyImages/dorian2013

Moderna to run three new infectious disease vaccine development programs, EU vaccine distribution begins

© GettyImages/Isparmo

Indonesia green lights China’s Sinovac COVID-19 vaccine

Follow us

Products

View more

Webinars

On-demand webinars

Marken Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

MilliporeSigma - Gene Therapy

Take the Right Path Upstream with MilliporeSigma

Viral Safety for mAb: Prevent, Detect, Remove